25th September 2026

The foundation of pharmaceutical quality assurance

As modern pharmaceutical products become increasingly sophisticated, lab equipment is evolving to meet analytical capabilities which extend far beyond traditional wet chemistry methods. These new forms of pharmaceutical analytical and lab equipment provide the technological foundation for the rigorous quality control and testing required to ensure drug products are fit for purpose.

The pharma sector’s commitment to patient safety and product efficacy is hugely dependent on the automation and analytical capabilities of the labs which manufacture them. This requires detecting impurities at parts-per-million levels, quantifying active pharmaceutical ingredients with at least 98% precision and characterising complex formulations containing multiple excipients and degradation products.

Regulatory frameworks such as the United States FDA’s GMP regulations [1] mandates that quality control labs owned by pharma manufacturers are adequately equipped and staffed, and that products are assessed by validated analytical methods. However, this requires substantial investment in analytical equipment, ensuring that instruments are maintained in qualified states and determining validated methods for generating reliable data that supports batch release decisions and regulatory submissions.

The economic implications of analytical testing extend beyond the direct costs of equipment and operations, significantly impacting manufacturing efficiency and product release timelines, as well as regulatory compliance. Inadequate analytical capabilities can drag out testing cycles, leading to a delay to product releases and an increase in the cost of carrying inventory. As a high-growth area of the pharma industry, the analytical testing market [2] is set  to hit $12bn by the start of the next decade, which is sure to have significant impact on operational efficiency and product quality.

Core analytical techniques in pharmaceutical quality control

The most common analytical method for quality control in pharma is high-performance liquid chromatography, which enables the separation and quantification of active pharmaceutical ingredients, impurities, degradation products and excipients within complex formulations. The versatility of HPLC systems lets them be applied to virtually all pharmaceutical compounds and formulations. Modern HPLC systems [3] achieve resolution enabling separation of closely related impurities, sensitivity detecting compounds at parts-per-million levels and precision with relative standard deviations below 1% for replicate injections, while ultra-high-performance liquid chromatography offers even superior resolution, sensitivity and speed than its conventional counterpart.

Liquid chromatography-mass spectrometry (LC-MS) represents the gold standard for identifying and characterising pharmaceutical impurities, [4] enabling the identification of unknown impurities through molecular weight determination and fragmentation pattern analysis. For standard oral dosage forms, dissolution testing [5] remains the critical form of quality control, measuring the rate and extent of drug release from tablets or capsules under standardized conditions that simulate physiological environments.  

Laboratory automation and digital integration

Lab automation technologies are designed to automate and optimise existing scientific workflows, from robotic sample preparation systems and automated liquid handling platforms to laboratory information management systems (LIMS) [6]. These collectively improve testing throughput, reduce manual labour, minimise human error and enhance data integrity. Robotic sample preparation systems automate repetitive tasks including weighing, dilution, extraction and filtration, helping to substantially save time and introduce variability through manual execution. Automated liquid handling platforms can precisely dispense reagents and samples in volumes ranging from microlitres to millilitres, improving accuracy and reproducibility while enabling high-throughput screening applications. This helps to create end-to-end workflows that minimise manual intervention, reduce turnaround times and improve the quality of data by eliminating transcription errors and sample mix-ups.

LIMS platforms manage sample registration, test assignment, result entry and specification checking, generating a report at the end to help maintain audit trails which document all system interactions and data modifications. Integrating LIMS with analytical instruments enables electronic data capture, while using it to inform enterprise resource planning systems facilitates batch release workflows and inventory management.

Automating laboratory processes requires careful consideration of workflow analysis, equipment selection and validation requirements. Successful automation projects begin with a comprehensive assessment of current workflows to identify bottlenecks, high-volume repetitive tasks and manual operations that are most prone to human error. Be sure to consider throughput requirements, flexibility for method changes, integration capabilities with existing systems and vendor support for validation and ongoing maintenance.

Method validation and regulatory compliance requirements

Analytical method validation is the process of demonstrating that analytical procedures suit for their intended purposes, generating reliable data supporting quality decisions and regulatory submissions. Based on International Council for Harmonisation guideline ICH Q2(R1), the key validation parameter is specificity [7] : the ability to unequivocally assess analytes in the presence of other components. This ensures that methods used will only measure the intended analytes without interference from impurities, degradation products or excipients. Meanwhile, accuracy is defined as the closeness of measured values to true values; most commonly, it is evaluated through recovery studies which analyse samples spiked with known quantities of analytes.

Equipment qualification is a complementary assessment to method validation, and ensures that analytical instruments perform as intended and remain in qualified states throughout their operational lives. This process encompasses:

• design qualification
• to establish user requirements and equipment specifications installation qualification
• to verify correct installation and configuration operational qualification
• demonstrating that instruments perform according to specifications across operating ranges performance qualification
• confirming that instruments generate acceptable results for intended applications

The ongoing maintenance [8] of qualified states requires the implementation of preventive maintenance programs, as well as periodic performance verification and change control procedures. This ensures that that modifications will not compromise instrument performance or data quality.

Industry platforms connecting pharmaceutical laboratories with equipment suppliers

CPHI & PMEC India, [9] taking place across Delhi from 23-26 November 2026, features dedicated exhibition zones for lab equipment, bringing together analytical instrument manufacturers, automation suppliers and laboratory service providers. Based at the IEML in Greater Noida, the PMEC part of the show lets pharmaceutical laboratories evaluate pharmaceutical analytical equipment innovations, compare lab equipment pharma offerings from multiple suppliers and engage directly with technical specialists who can address application-specific requirements and regulatory compliance considerations.

PMEC India will feature a significant concentration of analytical equipment suppliers, creating opportunities for comprehensive technology assessment within compressed timeframes. The show is designed to enable laboratory managers and quality professionals to efficiently evaluate quality control instruments, discuss analytical testing pharma requirements, and assess laboratory automation solutions to address throughput, data integrity and operational efficiency objectives.

These kinds of industry events offer invaluable opportunities to see equipment in action, with presentations and content tracks to showcase the technical work which led to the creation of this analytical methodology. The show also gives professionals from across the pharma supply chain the chance to establish relationships with equipment suppliers and service providers who can support laboratory operations through supply, installation, qualification and ongoing maintenance.

Conference programming addressing regulatory developments, emerging analytical technologies and case studies of successful laboratory automation implementations offers complementary strategic context and practical insights to inform any investment decisions. For pharmaceutical quality control professionals serving Indian markets or establishing analytical capabilities for regional manufacturing operations, such platforms provide concentrated access to the analytical equipment ecosystem, enabling evaluation of pharmaceutical analytical equipment innovations, assessment of lab equipment pharma suppliers and establishment of relationships supporting laboratory excellence and regulatory compliance in increasingly sophisticated and demanding pharmaceutical quality environments.